AI is about to change healthcare. These 44 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Atlanticus, you need to be comfortable with a near prime and underserved consumer focus, a funding model tied to wholesale and securitization markets, and the execution risk around the large Mercury acquisition. The latest earnings beat and faster Mercury integration progress support the near term catalyst around integration benefits, while the key risk remains any setback in realizing those expected cost efficiencies and repricing gains. The preferred dividend news itself does not materially change that risk reward balance.
The most relevant update here is the second quarter 2026 earnings release, which showed higher net income and diluted EPS from continuing operations alongside management commentary about accelerated Mercury integration and stable credit behavior. Those results speak directly to the central catalyst of whether the enlarged platform can translate scale into sustainable profitability while keeping credit and funding in check. How durable that performance proves to be as Mercury is fully absorbed will be a central question for shareholders.
Yet even with stronger earnings and faster integration, investors should be aware of how much still depends on successfully executing the Mercury integration and avoiding any prolonged slip in...
Read the full narrative on Atlanticus Holdings (it's free!)
Atlanticus Holdings' narrative projects $5.3 billion revenue and $387.5 million earnings by 2029. This requires 103.2% yearly revenue growth and a $261.8 million earnings increase from $125.7 million.
Uncover how Atlanticus Holdings' forecasts yield a $121.80 fair value, a 26% upside to its current price.
Some of the most optimistic analysts were assuming revenue could reach about US$5.1 billion and earnings US$484.8 million, which is far more bullish than the baseline view and leans heavily on Mercury related cost and yield benefits that this latest earnings and integration update may either reinforce or challenge over time.
Explore 6 other fair value estimates on Atlanticus Holdings - why the stock might be worth 40% less than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com